Sangamo BioSciences (SGMO) PT Lowered to $4 at Wells Fargo
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough lowered the price target on Sangamo BioSciences (NASDAQ: SGMO) to $4.00 (from $5.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Sangamo picks Lilly and PTC as buyers in bankruptcy auction
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
- Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
